 |
|
|
| |
HCV elimination in homeless patients is possible: a pooled real-world analysis of homeless patients with HCV treated with sofosbuvir/velpatasvir (SOF/VEL) for 12 weeks
|
| |
| |
AASLD 2020 virtual Nov 11-16
Reported by Jules Levin
Rodriguez-Tajes S1, O'Loan J2, Garcia-Retortillo M3, Pérez Hernández F4, Barrett L5, Teti E6, Ryan P7, Fraser C8, Guerra Veloz MF9, Macedo G10, Morano L11, De Lédinghen V12, Fenech M13, Martins A14, Ntalla I15, Hernandez C16, Mertens M16, Vanstraelen K16, Conway B17
1Liver Unit, Hospital Clinic Barcelona, IDIBAPS, CIBEREHD, Barcelona, Spain; 2Kombi Clinic & Medeco Inala, Brisbane, QLD, Australia; 3Liver Section, Gastroenterology Department, Hospital del Mar-Parc de Salut Mar, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain; 4Head of Digestive Disease Department, Complejo Hospitalario Nuestra Señora de Candelaria, Spain; 5Infectious Diseases, NSHA/Dalhousie University, Halifax, NS, Canada; 6Infectious Diseases Clinic, Tor Vergata University, Rome, Italy; 7Infanta Leonor Hospital, Madrid, Spain; 8Cool Aid Community Health Centre, Victoria, BC, Canada; 9Virgen Macarena University Hospital, Seville, Spain; 10Department of Gastroenterology and Hepatology, Centro Hospitalar, Porto; Faculty of Medicine, Porto, Portugal; 11Unit of Infectious Diseases, Alvaro Cunqueiro University Hospital, Vigo, Spain; 12Centre Hospitalier Universitaire Bordeaux, France; 13Queensland Injectors Health Network Ltd., Better Access Medical Clinic, Brisbane, QLD, Australia; 14Hospital Prof Dr Fernando Fonseca, Amadora, Portugal; 15Data Science and Biometrics, Epidemiology, Gilead Sciences Europe Ltd. UK; 16Medical Affairs, Gilead Sciences Europe Ltd. UK; 17Infectious Diseases, Vancouver Infectious Diseases Centre, Vancouver, BC, Canada
|
| |
|
|
|
|
|
